154 related articles for article (PubMed ID: 6369119)
1. Complement activation by the surface of Plasmodium falciparum infected erythrocytes.
Stanley HA; Mayes JT; Cooper NR; Reese RT
Mol Immunol; 1984 Feb; 21(2):145-50. PubMed ID: 6369119
[TBL] [Abstract][Full Text] [Related]
2. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
3. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
Brown EJ; Joiner KA; Frank MM
J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
[TBL] [Abstract][Full Text] [Related]
4. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
5. Guinea pig erythrocytes, after their contact with influenza virus, acquire the ability to activate the human alternative complement pathway through virus-induced desialation of the cells.
Lambré CR; Kazatchkine MD; Maillet F; Thibon M
J Immunol; 1982 Feb; 128(2):629-34. PubMed ID: 6459381
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of C3 subcomponents on red cells coated with complement in vitro.
Freedman J; Massey A
J Clin Pathol; 1980 Oct; 33(10):977-83. PubMed ID: 7430364
[TBL] [Abstract][Full Text] [Related]
7. Host cell factor CD59 restricts complement lysis of Plasmodium falciparum-infected erythrocytes.
Wiesner J; Jomaa H; Wilhelm M; Tony HP; Kremsner PG; Horrocks P; Lanzer M
Eur J Immunol; 1997 Oct; 27(10):2708-13. PubMed ID: 9368630
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum: modulation of surface antigenic expression of infected erythrocytes as revealed by cell fluorescence ELISA.
Baruch D; Glickstein H; Cabantchik ZI
Exp Parasitol; 1991 Nov; 73(4):440-50. PubMed ID: 1959571
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
Fearon DT
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
[TBL] [Abstract][Full Text] [Related]
10. Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria.
Pawluczkowycz AW; Lindorfer MA; Waitumbi JN; Taylor RP
J Immunol; 2007 Oct; 179(8):5543-52. PubMed ID: 17911641
[TBL] [Abstract][Full Text] [Related]
11. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Oct; 131(4):1930-5. PubMed ID: 6225800
[TBL] [Abstract][Full Text] [Related]
12. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
13. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
14. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural localization of the 150/130 Kd antigens in sexual and asexual blood stages of Plasmodium falciparum-infected human erythrocytes.
Uni S; Masuda A; Stewart MJ; Igarashi I; Nussenzweig R; Aikawa M
Am J Trop Med Hyg; 1987 May; 36(3):481-8. PubMed ID: 3555137
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of Human C1 Esterase Inhibitor Controls Complement Activation on Blood Stage
Kennedy AT; Wijeyewickrema LC; Huglo A; Lin C; Pike R; Cowman AF; Tham WH
J Immunol; 2017 Jun; 198(12):4728-4737. PubMed ID: 28484054
[TBL] [Abstract][Full Text] [Related]
17. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.
Lambre CR; Thibon M; Le Maho S; Di Bella G
Immunology; 1983 Jun; 49(2):311-9. PubMed ID: 6852870
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
Parker CJ; Wiedmer T; Sims PJ; Rosse WF
J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-Linked Immunosorbent Assay for Activation of the Classical Complement Pathway by Plasmodium falciparum-Infected Erythrocyte Surface Antigen-Specific Antibodies.
Larsen MD; Bayarri-Olmos R; Garred P; Hviid L
Methods Mol Biol; 2022; 2470():673-678. PubMed ID: 35881382
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of C3b inhibition of immune complex induced C1 activation.
Ziccardi RJ
Mol Immunol; 1988 Dec; 25(12):1339-46. PubMed ID: 3237217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
